Lapsed Aug 19, 2026 on the fee record · Medium confidence
20-year base term ends Mar 5, 2029
Why Medium: A terminal disclaimer is on file (approved) with no resolved reference, so the term may end earlier.
Third maintenance fee unpaid; grace period ended.
Mar 5, 2009
Aug 19, 2026
Aug 19, 2014
Mar 5, 2029
Its term would have run to Mar 5, 2029: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 5, 2009, when application 12/398,941, the earliest non-provisional in its chain, was filed (this one was filed May 6, 2013) | Mar 5, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Aug 19, 2026 | High confidence |
| Computed term end | The steps above, in order | Aug 19, 2026 | Medium confidence |
This family
| US 8,258,962 | In force Nov 2030 | Nov 2030 |
| US 8,542,123 | In force Mar 2029 | Mar 2029 |
| US 8,810,409 | this patent Aug 2026 | Aug 2026 |
| US 9,060,708 | In force Mar 2029 | Mar 2029 |
| US 9,258,035 | In force Mar 2029 | Mar 2029 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 28, 2013 Reel 31103, frame 708 | Robertson, Timothy; Zdeblick, Mark | Proteus Biomedical, Inc. | Assignment of Assignor's Interest |
| Aug 28, 2013 Reel 31122, frame 236 | Proteus Biomedical, Inc. | Proteus Digital Health, Inc. | Change of Name |
| Feb 2, 2022 Reel 58868, frame 655 | Proteus Digital Health, Inc. | Otsuka America Pharmaceutical, Inc. | Assignment of Assignor's Interest |
| Feb 2, 2022 Reel 58868, frame 668 | Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Aug 19, 2026. We will not guess the cap.